Our training
-
Understanding Cancer: Basics of cells and treatments
Summary: This short module gives anyone working in cancer a fast, clear grounding in how cancer develops and how treatments work. It is designed to strengthen core knowledge and boost confidence across all cancer‑related roles. A sharp, accessible introduction to the science that underpins everyday practice.
Duration: 30 minutes
Cost: Free
-
Understanding Cancer: Metastasis
Summary: This e-learning session introduces how and why cancer spreads (metastasis) and what this means for patients and their care.
Duration: 45 minutes
Cost: Free
-
Understanding Cancer: Chemotherapy
Summary: Coming Soon!
Duration: 45 minutes
Cost: Free
-
Introduction to Radiotherapy
Summary: Coming October 2026
-
1-2-3 Approach Health Inequalities
Summary: The 123 Approach is a training and education package aimed at cancer care professionals to support them to reduce health inequalities in their organisation and own work.
Duration: 90 minutes
Cost: Free
-
Reducing Weight Stigma in Healthcare Practice: Person-Centred Approaches
Summary: This e-learning session explores weight stigma (sometimes referred to as weight bias), who it affects, how it impacts people’s health, well being, and experience of healthcare.
Duration: 45 minutes
Cost: Free
-
Paediatric Weight Management and Activity
Summary: How to have meaningful conversations with young people and their families about weight and activity.
Duration: 30 minutes
Cost: Free
-
Podcasts: Cancer Conversations with CMCA
Summary: "Breast symptoms are common — and not every symptom is cancer." Our 'Cancer Conversations with CMCA' podcast brings Primary and Secondary Care clinicians together across 6 episodes to discuss difficult, topical issues in breast cancer. Created by CMCA, Professionally recorded and produced by Kenyons & Co, Liverpool; funded by AstraZeneca, who had no involvement in its creation, content or organisation.
Duration: 20-45 minutes
Cost: Free
-
Immunotherapy
Summary: As the use of immunotherapy continues to grow, healthcare professionals across primary care, acute care and oncology settings are increasingly likely to encounter patients experiencing immune-related adverse events (irAEs).
